Evidence map›Paper›PMID 33489936›Full record

ArticleFrontiers in cellular and infection microbiology2020

Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation.

Biana Bernshtein, Aharon Nachshon, Miri Shnayder, Lauren Stern, Selmir Avdic, Emily Blyth, David Gottlieb, Allison Abendroth, Barry Slobedman, Noam Stern-Ginossar and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Biana BernshteinDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Aharon NachshonDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Miri ShnayderDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Lauren SternDiscipline of Infectious Diseases and Immunology, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia.
Selmir AvdicSydney Cellular Therapies Laboratory, Westmead Institute for Medical Research, Westmead, NSW, Australia.
Emily BlythSydney Cellular Therapies Laboratory, Westmead Institute for Medical Research, Westmead, NSW, Australia.
David GottliebBMT and Cell Therapies Unit, Westmead Hospital, Sydney, NSW, Australia.
Allison AbendrothDiscipline of Infectious Diseases and Immunology, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia.
Barry SlobedmanDiscipline of Infectious Diseases and Immunology, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia.
Noam Stern-GinossarDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Michal SchwartzDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Weizmann Institute of Science · ILThe University of Sydney · AUWestmead Institute for Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) is a widespread pathogen establishing a latent infection in its host. HCMV reactivation is a major health burden in immunocompromised individuals, and is a major cause of morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Here we determined HCMV genomic levels using droplet digital PCR in different peripheral blood mononuclear cell (PBMC) populations in HCMV reactivating HSCT patients. This high sensitivity approach revealed that all PBMC populations harbored extremely low levels of viral DNA at the peak of HCMV DNAemia. Transcriptomic analysis of PBMCs from high-DNAemia samples revealed elevated expression of genes typical of HCMV specific T cells, while regulatory T cell enhancers as well as additional genes related to immune response were downregulated. Viral transcript levels in these samples were extremely low, but remarkably, the detected transcripts were mainly immediate early viral genes. Overall, our data indicate that HCMV DNAemia is associated with distinct signatures of immune response in the blood compartment, however it is not necessarily accompanied by substantial infection of PBMCs and the residual infected PBMCs are not productively infected.

Indexed as

CytomegalovirusHematopoietic Stem Cell TransplantationDNA, ViralHumansImmunocompromised HostLeukocytes, MononuclearDNA, Viralblood compartmenthematopoietic stem cell transplantationhuman cytomegalovirusperipheral blood mononuclear cellreactivation

Identifiers

PMID33489936
PMCPMC7820775
OpenAlexW3118239309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.